Results from this randomized trial showed that the ADR, particularly for advanced and large adenomas, was substantially higher for the G-EYE®
SMART Medical has now commenced clinical collaboration with NYU Langone Health introducing its newly FDA-cleared G-EYE® 760 Colonoscope series.
SMART Medical's G-EYE® Colonoscope, incorporating the G-EYE® Balloon Technology to control the endoscope's field of view and positioning during colonoscopy, was cleared for marketing in the USA by the FDA.
This recent Network Meta-analysis is comparing very different modalities, attempting to increase Adenoma Detection Rates (ADR) in the colon. The detailed and comprehensive analysis concludes in a very thorough manner that no other product or tool can increase ADR the way the G-EYE® does.
SMART's G-EYE® 760R colonoscope, incorporating its G-EYE® Balloon Technology designed to increase the detection of cancerous polyps in colonoscopy, will become available by FUJIFILM Europe with its state-of-the-art ELUXEO system, as part of the newly formed strategic distribution partnership with FUJIFILM Corporation.
Improved Adenoma Detection Rate (ADR) substantiates G-EYE® colonoscopy as the preferable solution by not only increasing ADR but also reducing adenoma miss rates at the same time.
With 28% more adenomas detected than with conventional colonoscopes G-EYE® has the potential to become a standard of care in colonoscopy, not only for screening but also for indicated and index colonoscopies